Abstract Background In recent years, ESBL/AmpC-producing Escherichia coli (ESBL/AmpC-EC) have been isolated with increasing frequency from animals, food, environmental sources and humans. With incomplete and scattered evidence, the contribution to the human carriage burden from these reservoirs remains unclear. Objectives To quantify molecular similarities between different reservoirs as a first step towards risk attribution. Methods Pooled data on ESBL/AmpC-EC isolates were recovered from 35 studies in the Netherlands comprising >27 000 samples, mostly obtained between 2005 and 2015. Frequency distributions of ESBL/AmpC genes from 5808 isolates and replicons of ESBL/AmpC-carrying plasmids from 812 isolates were compared across 22 reservoirs through proportional similarity indices (PSIs) and principal component analyses (PCAs). Results Predominant ESBL/AmpC genes were identified in each reservoir. PCAs and PSIs revealed close human–animal ESBL/AmpC gene similarity between human farming communities and their animals (broilers and pigs) (PSIs from 0.8 to 0.9). Isolates from people in the general population had higher similarities to those from human clinical settings, surface and sewage water and wild birds (0.7–0.8), while similarities to livestock or food reservoirs were lower (0.3–0.6). Based on rarefaction curves, people in the general population had more diversity in ESBL/AmpC genes and plasmid replicon types than those in other reservoirs. Conclusions Our ‘One Health’ approach provides an integrated evaluation of the molecular relatedness of ESBL/AmpC-EC from numerous sources. The analysis showed distinguishable ESBL/AmpC-EC transmission cycles in different hosts and failed to demonstrate a close epidemiological linkage of ESBL/AmpC genes and plasmid replicon types between livestock farms and people in the general population. Introduction Since 2000, the incidence of ESBL-producing Enterobacteriaceae infections increased globally both in hospitals and in the community.1–3 In parallel, ESBL/AmpC-producing Escherichia coli (ESBL/AmpC-EC) have increasingly been reported in livestock, in the food chain and in companion animals.4–9 The public health burden of these animal reservoirs as sources of human infections remains an issue of controversy.10–17 Resistance transmission pathways for ESBL/AmpC-EC are complex. Bacterial populations can acquire resistance genes horizontally through mobile genetic elements in a wide variety of intestinal or extra-intestinal environments.13 There are multiple direct and indirect transmission routes from animal or environmental sources to humans and vice versa.13 Parallel occurrence of ESBL gene subtypes, plasmids and/or bacterial clones in livestock and humans has been documented and is considered evidence of poultry being an important source of animal-associated ESBL/AmpC-EC infections in humans.11,13,18 A study based on WGS showed direct transmission of ESBL-producing E. coli between pigs and pig farmers, whereas transmission to humans from poultry through the food chain was not considered to be likely.19 This study also demonstrated widespread prevalence of specific plasmids, which is compatible with a scenario of plasmid-mediated transmission between different reservoirs.19 Despite the availability of numerous studies on molecular characteristics, the epidemiology of ESBL/AmpC-EC is not fully understood.20–31,E. coli ESBL types, phylogroups and antimicrobial susceptibilities from a meta-collection of ESBL/AmpC-EC isolates (n = 1329) across humans, livestock and companion animal populations have only been compared in a single study.18 The purpose of the present study was to investigate molecular relatedness in a pooled analysis of a substantially larger collection of ESBL/AmpC-EC isolates from diverse human and animal populations, food and environmental reservoirs in the Netherlands. The isolate collection was analysed by dimension reduction techniques to quantify the abundance, diversity and similarity of genes, plasmid replicons and strains between the different reservoirs as a first step towards an analysis of attribution. Methods Selection of studies Peer-reviewed publications containing collections of ESBL/AmpC-EC in the Netherlands were systematically reviewed using PubMed (Figure S1, available as Supplementary data at JAC Online). The search strategy consisted of the combination of terms ‘ESBL’, ‘extended-spectrum’ or ‘β-lactamase’, with either terms related to the bacterial species of interest (i.e. ‘Escherichia coli’ or ‘E. coli’) or terms referring to the country where isolates were collected (‘the Netherlands’ or ‘Dutch’). The last search was done in February 2016. Studies were only included when they contained isolates with at least ESBL/AmpC gene typing information for all gene groups found; this was the primary outcome. Exclusion criteria were applied to studies containing only isolates collected prior to 2000, reports of outbreak investigations, studies that focused on the molecular characterization of only specific plasmids and/or ESBL/AmpC genes, abstracts from scientific conferences and studies written in languages other than English or Dutch. Other reasons for exclusion were the lack of gene typing data for any of the gene groups CTX-M, TEM or SHV and the impossibility of data extraction at the isolate level when reporting of specific genes was aggregated (Figure S1). From the 25 publications selected after full text screening, partners within the ESBLAT (ESBL Attribution) research consortium (http://www.1health4food.nl/nl/show/ESBL-attributie-3.htm) provided detailed data from laboratory records (n = 20 studies).7,8,11,12,21–26,28,29,31–38 Data were exclusively extracted from the publications for five studies.20,27,30,39,40 Additionally, ESBLAT partners provided finalized data from epidemiological studies within the consortium (n = 9 studies, from which 3 publications became available after the systematic search)41–43 and from the isolates collected as part of the Dutch Antimicrobial National Surveillance System (MARAN) for years 2012 to 2016 (Figure S1).44 A total of 35 studies were included for the pooled analysis (Table S1 and Figure S1). Data extraction and synthesis From each of the selected studies the number of ESBL genes from the CTX-M, TEM or SHV families associated with phenotype 2be (ESBL-producing),45 and the number of AmpC plasmid-mediated genes from the CMY, ACC, ACT, DHA and MIR families were extracted. Additionally, where available, the number of replicon types of plasmids harbouring ESBL/AmpCs identified by PCR-based replicon typing (PBRT) and/or number of E. coli genotypes identified by MLST were extracted (Table S1 and Figure S2). Multi-F replicons were grouped into a single IncF category. Information on the source of origin of the isolates was used to aggregate the empirical frequency distributions (in genes, replicons and strain types) by reservoirs per study and across studies in the total pool of isolates (Table S1 and Figure S2). Isolates from human clinical settings (hospitals, general practitioners and long-term care facilities) were grouped by type of sample (faecal, urine, blood samples and an aggregation of samples from respiratory infections, wounds and other origins); one reservoir represented people in the general population with isolates originating from people in the open community; two reservoirs represented the human farming communities who were in contact with pigs and broilers; animal species constituted independent reservoirs: dogs kept as pets, wild birds and production animals (veal calves, dairy cattle, pigs, broilers and laying hens); meat samples were also classified as independent reservoirs depending on the origin of samples as chicken meat at retail and at the slaughterhouse, turkey meat and beef at retail and veal meat at the slaughterhouse; finally, three environmental reservoirs represented wastewater and surface water for recreational and non-recreational sites (Table S1 and Figure S2). Other possible independent reservoirs reported in the selected studies were excluded to avoid large sampling uncertainties when the final aggregation yielded <25 isolates (e.g. clinical samples from cats and horses, environmental samples from laying hens and meat retail samples other than chicken, beef or turkey). Pooled analyses Visual comparisons of relative frequencies for genes, plasmids and E. coli sequence types between the different reservoirs were obtained by bar charts using Sigma Plot (version 13, Systat Software Inc, San José, CA, USA). These relative frequencies formed the basis of the data analysed in the subsequent stages. The relative frequencies were defined based on the total number of ESBL/AmpC genes and/or plasmid replicons instead of the total number of isolates. Firstly, a pairwise quantification of the associations between the frequency distributions of genes and plasmids in the reservoirs was performed. The proportional similarity index (PSI) was used, which is defined as PSI = 1 − 0.5∑k|pk−qk|, where pk is the relative frequency of the gene or plasmid replicon subtype harbouring an ESBL/AmpC gene k in the first reservoir and qk is the relative frequency of subtype k in the second reservoir.46 CIs for PSI were calculated using 5000 bootstrap samples. Secondly, principal component analyses (PCAs) were performed for the pooled collection of genes, for the plasmid replicons and for the combination of replicons and genes.47 The dimension of the proportion profiles was reduced to the two main components in which each gene and replicon had a different load according to their contribution for differentiation of reservoirs. ESBL/AmpC gene and replicon types with relative frequencies below 0.05 in all reservoirs were excluded to avoid rare occurrences related to the number of samples. Unlike in most PCAs, relative frequencies were not scaled in relation to each other to keep the effect of relatively large variances of particular genes and/or plasmids between reservoirs. Bootstrap samples (5000 times) of the relative frequencies per reservoir were generated to account for sample uncertainty.48 Biplots of the space represented by the two principal components were constructed and preferences for the location of genes, replicons or their combination among the bootstrapped samples of the different reservoirs’ isolates were displayed. Finally, a rarefaction analysis was performed to evaluate the diversity of genes and plasmid replicons in the pooled collection of isolates per reservoir.49 All analyses were done in R (version 3.0.2; R Foundation for Statistical Computing, Vienna, Austria). Results Proximity of reservoirs according to ESBL/AmpC genes and plasmid replicon frequencies A total of 5808 ESBL/AmpC-EC isolates originating from >27 000 samples collected in 35 studies across 22 reservoirs were compiled (Table S1 and Figure S2). The pooled analyses were done in the total collection of isolates, in a subset of 863 isolates containing information on ESBL/AmpC-gene-carrying plasmid replicons and in a subset of 666 isolates with information on E. coli strain types (Table S1 and Figure S2). The prevalence of E. coli samples producing ESBL/AmpC across reservoirs was calculated or extracted from the selected publications and varied from low (<5% for human clinical blood samples, people in the general population, pig farmers and retail beef) to high (>60% for wastewater samples, broilers and retail chicken meat) (Table S1 and Figure S3). The analysis of the ESBL/AmpC-EC isolate collection provided a summary of the most common gene and plasmid replicon distributions in the different reservoirs (Figures 1 and 2). Genes blaCTX-M-1, blaCTX-M-14, blaCTX-M-15, blaSHV-12 and blaTEM-52 dominated the profile distributions of most reservoirs, except for broilers, human communities living and/or working on broiler farms, chicken meat at slaughterhouses and laying hens. In broilers, people working and/or living on broiler farms, chicken meat and laying hens, blaCMY-2 was frequently observed, while blaCTX-M-15 and blaCTX-M-14 were very rare or absent (Figure 1a). From the subset of 863 E. coli isolates with replicon typing information on ESBL/AmpC-harbouring plasmids, 812 formed collections of sufficient size to be analysed multivariately (Figure 2). The most common plasmid replicons were IncI1 and IncF, followed by smaller proportions of IncK, IncN, IncB/O and IncX1 (Figure 2a). Remarkably, IncF was absent in the broiler farming community and very low in chicken meat and broilers. Combined with the ESBL/AmpC gene data above, this again hints at a separate reservoir. The relative frequencies of ESBL/AmpC genes in this subset of isolates did not fundamentally differ from those in the complete pool (Figure S4). Figure 1. View largeDownload slide Pooled analysis of the ESBL/AmpC genes from 5808 E. coli isolates in human, animal, food and environmental reservoirs in the Netherlands. (a) Proportion of gene types over total number of genes collated per reservoir. (b) Pairwise PSI for gene types between reservoirs. Cells are shaded gradually according to PSI values [from 0 (no similarity in gene distribution) to 1 (identical distribution)]. (c) PCA on the bootstrapped samples of ESBL/AmpC gene frequencies per reservoir. Only the most discriminatory genes are plotted. Higher dispersion of point clouds indicates less confidence in the clustering and vice versa. Figure 1. View largeDownload slide Pooled analysis of the ESBL/AmpC genes from 5808 E. coli isolates in human, animal, food and environmental reservoirs in the Netherlands. (a) Proportion of gene types over total number of genes collated per reservoir. (b) Pairwise PSI for gene types between reservoirs. Cells are shaded gradually according to PSI values [from 0 (no similarity in gene distribution) to 1 (identical distribution)]. (c) PCA on the bootstrapped samples of ESBL/AmpC gene frequencies per reservoir. Only the most discriminatory genes are plotted. Higher dispersion of point clouds indicates less confidence in the clustering and vice versa. Figure 2. View largeDownload slide Pooled analysis of the plasmid replicons associated with production of ESBL/AmpC in 812 E. coli isolates from human, animal, food and environmental reservoirs in the Netherlands. (a) Proportion of replicon types over total number of replicons collated per reservoir. (b) Pairwise PSI for replicon types between reservoirs. Cells are shaded gradually according to PSI values [from 0 (no similarity in gene distribution) to 1 (identical distribution)]. (c) PCA on the bootstrapped samples of replicon frequencies per reservoir. Only the most discriminatory replicons are plotted. Higher dispersion of point clouds indicates less confidence in the clustering and vice versa. (d) PCA on the bootstrapped samples of replicon frequencies and gene frequencies (from the complete isolate pooled collection, n = 5808) per reservoir. Only the most discriminatory replicons and genes are plotted. Higher dispersion of point clouds indicates less confidence in the clustering and vice versa. Figure 2. View largeDownload slide Pooled analysis of the plasmid replicons associated with production of ESBL/AmpC in 812 E. coli isolates from human, animal, food and environmental reservoirs in the Netherlands. (a) Proportion of replicon types over total number of replicons collated per reservoir. (b) Pairwise PSI for replicon types between reservoirs. Cells are shaded gradually according to PSI values [from 0 (no similarity in gene distribution) to 1 (identical distribution)]. (c) PCA on the bootstrapped samples of replicon frequencies per reservoir. Only the most discriminatory replicons are plotted. Higher dispersion of point clouds indicates less confidence in the clustering and vice versa. (d) PCA on the bootstrapped samples of replicon frequencies and gene frequencies (from the complete isolate pooled collection, n = 5808) per reservoir. Only the most discriminatory replicons and genes are plotted. Higher dispersion of point clouds indicates less confidence in the clustering and vice versa. PSIs (Figure 1b) showed that most livestock or food-associated reservoirs did not have a high level of similarity with the ESBL/AmpC gene distributions from humans (average PSI <0.5), with the exception of livestock farmers, in whom the gene distributions were very similar to those of their animals (PSI of 0.8 for pig farming and 0.9 for broiler farming). The general and clinical human populations had relatively similar ESBL/AmpC gene profiles to water samples (PSI 0.6–0.8), wild birds (mainly ducks and waders), dogs, veal calves, pigs and beef (PSI 0.5–0.7). The least similar gene distributions to the human general and clinical populations were those of farming communities, chicken meat at slaughterhouses, broilers and laying hens (average PSI 0.3–0.4). The PSIs for plasmid replicon profiles in the subset of 812 isolates (Figure 2b) were very close to those determined for the ESBL/AmpC genes. CIs for the PSIs are provided in Tables S2 and S3 and Figure S3. PCAs on the ESBL/AmpC gene and replicon distributions visualized the genetic relatedness of ESBL/AmpC-EC across all reservoirs (Figure 1c and Figure 2c and d). For ESBL/AmpC genes (Figure 1c), the first principal component (explained variance 49%) was determined by the distinct abundance of blaCTX-M-15 (in human clinical populations, people in the general population and water sources), versus a higher occurrence of blaCTX-M-1 and/or blaCMY-2 (in meat samples, animals and people in farming communities). The second component (explained variance 32%) separated these latter reservoirs according to the relative abundance of blaCTX-M-1, blaCMY-2 and blaSHV-12. In dairy cattle, veal calves, pigs, the pig farming community, beef at retail and veal calf meat at the slaughterhouse, blaCTX-M-1 dominated the distributions; blaCMY-2 and/or blaSHV-12 were more frequently present in laying hens and chicken meat at the slaughterhouse. Broilers and the broiler farming community had a more intermediate position on the vertical axis due to their abundance of blaCMY-2, blaCTX-M-1 and blaSHV-12, and absence of blaCTX-M-14 and blaCTX-M-15. Genes from wild birds clustered relatively close to the human general and clinical populations. Genes from dogs, turkey meat and human clinical faecal isolates clustered close to the centre of the two component loadings. In the subset of eight reservoirs with sufficient replicon data (n = 812 isolates) the PCA showed proximities between reservoirs comparable with those seen for gene profiles (Figure 2c). The first component explained most variance (79%) and separated reservoirs with high abundance of IncF replicons (e.g. veal calves) from those with higher abundance of IncI1 (e.g. pigs). The second component (explained variance 13%) defined reservoirs with a distinct presence of IncK plasmids. A PCA including genes from the complete pool of isolates (n = 5808), together with the replicons from the subset of 812 isolates (Figure 2d), yielded comparable proximities, despite an increased variability within individual reservoirs which resulted in lower explained variance (69% for the two components). As a sensitivity analysis, another gene–replicon combined PCA was produced with gene frequencies only from isolates containing replicon typing. Again, a very similar pattern was shown (Figure S5). Rarefaction analysis of ESBL/AmpC genes and replicon types Rarefaction analysis per reservoir showed that the number of isolates in the analysis was enough to yield correct estimates for the diversity (i.e. most rarefaction curves approached a plateau for collected sample sizes).50 Rarefaction curves showed that sampling 40–80 isolates was sufficient to capture most of the molecular diversity (in genes and associated replicons) across reservoirs. The people in the general population, waste/surface water, dairy cattle, dogs, veal calves and human clinical urinary tract infection (UTI) isolates had the most diverse ESBL/AmpC gene pool (∼8–9 different genes) (Figure 3a). The least diverse gene pool was found in chicken meat at the slaughterhouse, broilers, laying hens and the farming community in direct contact with pigs and poultry (∼4 different genes). The diversity in plasmid replicon types associated with these genes was highest in people in the general population and in chicken meat at retail (∼6 different types) (Figure 3b). Figure 3. View largeDownload slide Rarefaction analysis for ESBL/AmpC genes from the complete pooled collection of 5808 E. coli isolates (a) and for replicon types in the subset of 812 isolates with replicon typing information (b). Figure 3. View largeDownload slide Rarefaction analysis for ESBL/AmpC genes from the complete pooled collection of 5808 E. coli isolates (a) and for replicon types in the subset of 812 isolates with replicon typing information (b). Sensitivity analyses The number of isolates and information available per reservoir varied over the years (Figure S6). As a result, potential shifts in gene and replicon frequency distributions over time may have been overlooked. Most isolates (97.8%) were collected between 2008 and 2015 (Figure S6), long after major changes were recorded in the epidemiology of ESBL/AmpCs—namely, the emergence of the CTX-M group of enzymes around the year 2000,3 and the emergence of AmpC plasmid-mediated β-lactamases in the poultry chain around the year 2006.32,51 In a sensitivity analysis, gene and plasmid replicon distributions per time period remained essentially unaltered across reservoirs (Table S4 and Table S5). MLST types A relatively low proportion of E. coli isolates in the collection were genotyped (MLST) (Table S1 and Figure S2). A detailed description of MLST types found in this subset is provided (Figure S7), but multivariate analysis was not appropriate given the low number of isolates and reservoirs to compare. ST131 was most commonly found in human UTIs (41%) followed by faecal isolates from the general population (16%), the broiler farming community (10%), broilers (6%) and dogs (5%); ST10 was present in all reservoirs (<10%) except for dogs. Other common MLST types were ST117 (17% in the broiler farming community), ST57 (38% in veal calves) and ST617 (38% in non-recreational surface water). Discussion The analysis of a large collection of isolates from different reservoirs showed that ESBL-AmpC gene distributions from all human, animal, meat and environmental reservoirs have a certain level of similarity (i.e. most ESBL/AmpC gene subtypes are found in each individual reservoir). However, an important observation is that most livestock or food-associated reservoirs did not show a high level of similarity in their gene profiles compared with humans from the general and clinical populations. This suggests that livestock reservoirs including poultry and poultry meat are not major contributors to ESBL/AmpC occurrence in humans, as has been suggested earlier by several research groups.6,16,52 Analogous findings are available for Salmonella Typhimurium DT104, demonstrating that this bacterium and its resistance genes are largely maintained within animal and human populations separately with limited transmission (although for Salmonella, vertical clonal dissemination dominates the transmission profile).53 Moreover, a quantitative microbial risk assessment of human exposure to ESBL/AmpC-EC through consumption of contaminated meat is indicative of low exposure through this route.54 Surprisingly, despite the high prevalence of ESBL/AmpC-EC in poultry, consumption of poultry meat contributed less than 20% to the total exposure through meat consumption. In contrast, owing to the consumption of raw meat, beef products contributed more than 75% to the total exposure through meat.54 It was remarkable that, in our study, the gene distribution in chicken meat at retail was distant from the reservoirs of broilers and chicken meat at the slaughterhouse. The reason behind this inconsistency might arise from meat from different countries where different ESBL types might be predominant (data on imports were not available)44 or, although never investigated, cross-contamination of meat by humans might be happening during processing or at retail. A high similarity was found in ESBL/AmpC gene distributions from humans in the general and clinical populations, which can be explained by the frequent contact between individuals from these niches. People in the general population showed the highest ESBL/AmpC gene and replicon diversities, indicating that this population is a receiving reservoir with numerous sources. We could not investigate the specific causes behind this high diversity in our study, but transmission routes in the community are complex, involving patients recently discharged from hospitals or non-domestic sources such as international travellers that might be contributing to a more diverse pool of genes.55 A high similarity in gene distributions was found in isolates from farmers and their animals, which is the result of intensive and direct contact as has previously been shown in studies in the pig and poultry sectors.19,21,28,37 Diversity in ESBL/AmpC genes among people in farming communities was lower (comparable to their animals) than in people from the general and clinical populations. This gives additional support to the hypothesis that direct contact is the most important route in the exchange of ESBL genes between reservoirs in farming communities. Additionally, living in close proximity to livestock production farms without occupational exposure to animals has not been associated with an increased ESBL/AmpC-EC carriage risk.42,56 A major research question that could be answered by longitudinal studies is whether this ESBL/AmpC-EC carriage in farmers is transient or a more permanent colonization. High molecular similarities between human and environmental reservoirs suggest a contribution of human wastewater to ESBL/AmpC-EC presence in surface water.57 The exposure of humans to contaminated surface water, for instance resulting from recreational swimming, requires further quantitative evaluation. The ESBL/AmpC genes in wild birds clustered close to humans. These animals may have acquired their ESBL/AmpC-EC through contaminated surface water. Such birds may act as vectors or even reservoirs for local dissemination.58–60 These observations are illustrative of the spread of ESBL/AmpC-EC to the environment and wildlife beyond the human and domestic animal populations exposed to antimicrobials and show that more studies directed at human exposure to ESBL/AmpC-EC in the environment are needed.61 Limitations of the current study material should be taken into consideration when results are interpreted. Details about the structure of some populations, especially those related to acquisition of non-domestic bacteria or genes (e.g. through importation of foods or international travel), were not available. All studies were scrutinized to determine whether they would contribute to a representative pool of ESBL/AmpC genes or associated plasmid replicons for each reservoir; however, selected studies were heterogeneous in terms of temporality, design and microbiological methods. In order to gain statistical power with more observations, isolates from longitudinal studies (e.g. dogs, pigs, veal calves and dairy cows) were pooled in the collection independently of the sampling time they were obtained. This may have led to a somewhat reduced variance because observations were not fully independent.22,36 Some of the studies (deliberately) did not include identification of plasmid-mediated AmpC genes in the reservoirs, but it is anticipated that AmpC occurrence in these reservoirs is relatively low.12 Unfortunately, replicon and MLST data were limited and specific gene–replicon or gene–replicon–MLST combinations could not be evaluated at the isolate level because of the nature of the collected data and the heterogeneity in methods used across studies. An important issue in ESBL/AmpC-EC epidemiology is that representation of some reservoirs in the scientific literature might be biased, for instance because human clinical samples are routinely analysed for ESBL/AmpC-EC, but not published in the peer-reviewed literature. It is also possible that some reservoirs have received disproportional attention compared with others. The latter is for instance the case for broilers, chicken meat or dairy cattle. This requires more unbiased large sampling efforts for studies that focus on attribution of different sources of ESBL/AmpC-EC. These aspects should be considered in future microbial risk assessments. These findings demonstrate the complex dynamics involved in the transmission of ESBL/AmpC-EC and show distinguishable epidemiological cycles between certain reservoirs, such as livestock (and meat) and humans in general and clinical populations. Information used in this study was mostly based on traditional molecular typing and WGS may provide a more refined picture in terms of relatedness between the bacterial host, all plasmids present and ESBL/AmpC genes. Likewise, although molecular relatedness has been established for some reservoirs, observational epidemiological or mathematical modelling studies are still required to understand the exact mode of transmission or its relative contribution in the case of multiple modes of transmission. To explore this multi-directionality, a combination of strong epidemiological designs, involving longitudinal studies with repeated sampling on the same individual or animal, and high-resolution molecular techniques, are required. The fact that the ESBL/AmpC epidemiology is driven by interactions between a variety of genes, plasmids and strains is a further complication that needs to be considered more explicitly in future studies. Acknowledgements Preliminary results from this study were presented at the Fourth International One Health EcoHealth Congress, Melbourne, Australia, 2016 (Abstract 404); the GLOBAL Good Agricultural Practices (G.A.P.) Summit, Amsterdam, The Netherlands, 2016 (Breakout Session – Risks in Livestock Production); and the International Conference on One Health Antimicrobial Resistance, Copenhagen, Denmark, 2015 (Poster 19). We would like to thank all people involved in the transfer of data. Funding This work was supported by the public private partnership 1Health4Food (TKI AF-12067, ESBL Voedsel Attributieve Risico's) and the Ministry of Economic Affairs (BO-22.04-008-001). Transparency declarations None to declare. Supplementary data Figures S1 to S7 and Tables S1 to S5 are available as Supplementary data at JAC Online. References 1 Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769– 75. Google Scholar CrossRef Search ADS PubMed 2 de Kraker ME, Jarlier V, Monen JC et al. The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system. Clin Microbiol Infect 2013; 19: 860– 8. Google Scholar CrossRef Search ADS PubMed 3 Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram-negative bacteria. Annu Rev Microbiol 2011; 65: 455– 78. Google Scholar CrossRef Search ADS PubMed 4 Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti Infect Ther 2008; 6: 733– 50. Google Scholar CrossRef Search ADS PubMed 5 Cortes P, Blanc V, Mora A et al. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 2010; 76: 2799– 805. Google Scholar CrossRef Search ADS PubMed 6 Doi Y, Paterson DL, Egea P et al. Extended-spectrum and CMY-type β-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010; 16: 33– 8. Google Scholar CrossRef Search ADS PubMed 7 Dierikx CM, van Duijkeren E, Schoormans AH et al. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. J Antimicrob Chemother 2012; 67: 1368– 74. Google Scholar CrossRef Search ADS PubMed 8 Hordijk J, Wagenaar JA, van de Giessen A et al. Increasing prevalence and diversity of ESBL/AmpC-type β-lactamase genes in Escherichia coli isolated from veal calves from 1997 to 2010. J Antimicrob Chemother 2013; 68: 1970– 3. Google Scholar CrossRef Search ADS PubMed 9 Kawamura K, Goto K, Nakane K et al. Molecular epidemiology of extended-spectrum β-lactamases and Escherichia coli isolated from retail foods including chicken meat in Japan. Foodborne Pathog Dis 2014; 11: 104– 10. Google Scholar CrossRef Search ADS PubMed 10 Smet A, Martel A, Persoons D et al. Broad-spectrum β-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiol Rev 2010; 34: 295– 316. Google Scholar CrossRef Search ADS PubMed 11 Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17: 873– 80. Google Scholar CrossRef Search ADS PubMed 12 Voets GM, Platteel TN, Fluit AC et al. Population distribution of β-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 2012; 7: e52102. Google Scholar CrossRef Search ADS PubMed 13 Lazarus B, Paterson DL, Mollinger JL et al. Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review. Clin Infect Dis 2015; 60: 439– 52. Google Scholar CrossRef Search ADS PubMed 14 Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev 2011; 24: 718– 33. Google Scholar CrossRef Search ADS PubMed 15 Ewers C, Bethe A, Semmler T et al. Extended‐spectrum β‐lactamase‐producing and AmpC‐producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect 2012; 18: 646– 55. Google Scholar CrossRef Search ADS PubMed 16 Collignon P, Aarestrup FM, Irwin R et al. Human deaths and third-generation cephalosporin use in poultry, Europe. Emerg Infect Dis 2013; 19: 1339– 40. Google Scholar CrossRef Search ADS PubMed 17 Chang Q, Wang W, Regev‐Yochay G et al. Antibiotics in agriculture and the risk to human health: how worried should we be? Evol Appl 2015; 8: 240– 7. Google Scholar CrossRef Search ADS PubMed 18 Valentin L, Sharp H, Hille K et al. Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs. Int J Med Microbiol 2014; 304: 805– 16. Google Scholar CrossRef Search ADS PubMed 19 de Been M, Lanza VF, de Toro M et al. Dissemination of cephalosporin resistance genes between Escherichia coli strains from farm animals and humans by specific plasmid lineages. PLoS Genet 2014; 10: e1004776. Google Scholar CrossRef Search ADS PubMed 20 van der Bij AK, Peirano G, Goessens WH et al. Clinical and molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam area, Netherlands. Antimicrob Agents Chemother 2011; 55: 3576– 8. Google Scholar CrossRef Search ADS PubMed 21 Dierikx C, van der Goot J, Fabri T et al. Extended-spectrum-β-lactamase- and AmpC-β-lactamase-producing Escherichia coli in Dutch broilers and broiler farmers. J Antimicrob Chemother 2013; 68: 60– 7. Google Scholar CrossRef Search ADS PubMed 22 Hordijk J, Mevius DJ, Kant A et al. Within-farm dynamics of ESBL/AmpC-producing Escherichia coli in veal calves: a longitudinal approach. J Antimicrob Chemother 2013; 68: 2468– 76. Google Scholar CrossRef Search ADS PubMed 23 Hordijk J, Schoormans A, Kwakernaak M et al. High prevalence of fecal carriage of extended spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs. Front Microbiol 2013; 4: 242. Google Scholar CrossRef Search ADS PubMed 24 Veldman K, van Tulden P, Kant A et al. Characteristics of cefotaxime-resistant Escherichia coli from wild birds in the Netherlands. Appl Environ Microbiol 2013; 79: 7556– 61. Google Scholar CrossRef Search ADS PubMed 25 Blaak H, de Kruijf P, Hamidjaja RA et al. Prevalence and characteristics of ESBL-producing E. coli in Dutch recreational waters influenced by wastewater treatment plants. Vet Microbiol 2014; 171: 448– 59. Google Scholar CrossRef Search ADS PubMed 26 Huijbers PM, Graat EA, Haenen AP et al. Extended-spectrum and AmpC β-lactamase-producing Escherichia coli in broilers and people living and/or working on broiler farms: prevalence, risk factors and molecular characteristics. J Antimicrob Chemother 2014; 69: 2669– 75. Google Scholar CrossRef Search ADS PubMed 27 Blaak H, Lynch G, Italiaander R et al. Multidrug-resistant and extended spectrum β-lactamase-producing Escherichia coli in Dutch surface water and wastewater. PLoS One 2015; 10: e0127752. Google Scholar CrossRef Search ADS PubMed 28 Dohmen W, Bonten MJ, Bos ME et al. Carriage of extended-spectrum β-lactamases in pig farmers is associated with occurrence in pigs. Clin Microbiol Infect 2015; 21: 917– 23. Google Scholar CrossRef Search ADS PubMed 29 Koningstein M, Leenen MA, Mughini-Gras L et al. Prevalence and risk factors for colonization with extended-spectrum cephalosporin-resistant Escherichia coli in children attending daycare centers: a cohort study in the Netherlands. J Pediatric Infect Dis Soc 2015; 4: e93– 9. Google Scholar PubMed 30 Pacholewicz E, Liakopoulos A, Swart A et al. Reduction of extended-spectrum-β-lactamase- and AmpC-β-lactamase-producing Escherichia coli through processing in two broiler chicken slaughterhouses. Int J Food Microbiol 2015; 215: 57– 63. Google Scholar CrossRef Search ADS PubMed 31 Day M, Rodríguez I, van Essen-Zandbergen A et al. Diversity of STs, plasmids and ESBL genes among Escherichia coli from humans, animals and food in Germany, the Netherlands and the UK. J Antimicrob Chemother 2016; 71: 1178– 82. Google Scholar CrossRef Search ADS PubMed 32 Dierikx C, van Essen-Zandbergen A, Veldman K et al. Increased detection of extended spectrum β-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet Microbiol 2010; 145: 273– 8. Google Scholar CrossRef Search ADS PubMed 33 Dierikx CM, van der Goot JA, Smith HE et al. Presence of ESBL/AmpC-producing Escherichia coli in the broiler production pyramid: a descriptive study. PLoS One 2013; 8: e79005. Google Scholar CrossRef Search ADS PubMed 34 Hordijk J, Wagenaar JA, Kant A et al. Cross-sectional study on prevalence and molecular characteristics of plasmid mediated ESBL/AmpC-producing Escherichia coli isolated from veal calves at slaughter. PLoS One 2013; 8: e65681. Google Scholar CrossRef Search ADS PubMed 35 Blaak H, Hamidjaja RA, van Hoek AH et al. Detection of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli on flies at poultry farms. Appl Environ Microbiol 2014; 80: 239– 46. Google Scholar CrossRef Search ADS PubMed 36 Baede VO, Wagenaar JA, Broens EM et al. Longitudinal study of extended-spectrum-β-lactamase- and AmpC-producing Enterobacteriaceae in household dogs. Antimicrob Agents Chemother 2015; 59: 3117– 24. Google Scholar CrossRef Search ADS PubMed 37 Huijbers PM, van Hoek AH, Graat EA et al. Methicillin-resistant Staphylococcus aureus and extended-spectrum and AmpC β-lactamase-producing Escherichia coli in broilers and in people living and/or working on organic broiler farms. Vet Microbiol 2015; 176: 120– 5. Google Scholar CrossRef Search ADS PubMed 38 van Hoek AH, Schouls L, van Santen MG et al. Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community. PLoS One 2015; 10: e0129085. Google Scholar CrossRef Search ADS PubMed 39 Kluytmans JA, Overdevest IT, Willemsen I et al. Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 2013; 56: 478– 87. Google Scholar CrossRef Search ADS PubMed 40 Paltansing S, Kraakman ME, Ras JM et al. Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother 2013; 68: 40– 5. Google Scholar CrossRef Search ADS PubMed 41 Gonggrijp MA, Santman-Berends IM, Heuvelink AE et al. Prevalence and risk factors for extended-spectrum β-lactamase- and AmpC-producing Escherichia coli in dairy farms. J Dairy Sci 2016; 99: 9001– 13. Google Scholar CrossRef Search ADS PubMed 42 Wielders C, van Hoek A, Hengeveld P et al. Extended-spectrum β-lactamase-and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area. Clin Microbiol Infect 2017; 23: 120.e1– 8. Google Scholar CrossRef Search ADS 43 van den Bunt G, Liakopoulos A, Mevius DJ et al. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage. J Antimicrob Chemother 2017; 72: 589– 95. Google Scholar CrossRef Search ADS PubMed 44 Dutch Food and Consumer Product Safety Authority (NVWA), Wageningen Bioveterinary Research. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands (MARAN) Reports 2012–2016. http://www.wur.nl/nl/Expertises-Dienstverlening/Onderzoeksinstituten/Bioveterinary-Research/Publicaties/MARAN-Rapporten.htm. 45 Lahey Clinic. β-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. https://www.lahey.org/studies/. 46 Garrett N, Devane ML, Hudson JA et al. Statistical comparison of Campylobacter jejuni subtypes from human cases and environmental sources. J Appl Microbiol 2007; 103: 2113– 21. Google Scholar CrossRef Search ADS PubMed 47 Shlens J. A Tutorial on Principal Component Analysis. https://www.cs.cmu.edu/∼elaw/papers/pca.pdf. 48 Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statist Sci 1986; 1: 54– 77. Google Scholar CrossRef Search ADS 49 Hurlbert SH. The nonconcept of species diversity: a critique and alternative parameters. Ecology 1971; 52: 577– 86. Google Scholar CrossRef Search ADS PubMed 50 Colwell RK, Mao CX, Chang J. Interpolating, extrapolating, and comparing incidence-based species accumulation curves. Ecology 2004; 85: 2717– 27. Google Scholar CrossRef Search ADS 51 Smet A, Martel A, Persoons D et al. Diversity of extended-spectrum β-lactamases and class C β-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms. Antimicrob Agents Chemother 2008; 52: 1238– 43. Google Scholar CrossRef Search ADS PubMed 52 Overdevest I, Willemsen I, Rijnsburger M et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 2011; 17: 1216– 22. Google Scholar CrossRef Search ADS PubMed 53 Mather AE, Reid SW, Maskell DJ et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 2013; 341: 1514– 7. Google Scholar CrossRef Search ADS PubMed 54 Evers EG, Pielaat A, Smid JH et al. Comparative exposure assessment of ESBL-producing Escherichia coli through meat consumption. PLoS One 2017; 12: e0169589. Google Scholar CrossRef Search ADS PubMed 55 Karanika S, Karantanos T, Arvanitis M et al. Fecal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis 2016; 63: 310– 8. Google Scholar CrossRef Search ADS PubMed 56 Huijbers PM, de Kraker M, Graat EA et al. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density. Clin Microbiol Infect 2013; 19: E256– 9. Google Scholar CrossRef Search ADS PubMed 57 Brechet C, Plantin J, Sauget M et al. Wastewater treatment plants release large amounts of extended-spectrum β-lactamase-producing Escherichia coli into the environment. Clin Infect Dis 2014; 58: 1658– 65. Google Scholar CrossRef Search ADS PubMed 58 Bonnedahl J, Drobni M, Gauthier-Clerc M et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One 2009; 4: e5958. Google Scholar CrossRef Search ADS PubMed 59 Pinto L, Radhouani H, Coelho C et al. Genetic detection of extended-spectrum β-lactamase-containing Escherichia coli isolates from birds of prey from Serra da Estrela natural reserve in Portugal. Appl Environ Microbiol 2010; 76: 4118– 20. Google Scholar CrossRef Search ADS PubMed 60 Hernandez J, Johansson A, Stedt J et al. Characterization and comparison of extended-spectrum β-lactamase (ESBL) resistance genotypes and population structure of Escherichia coli isolated from Franklin's gulls (Leucophaeus pipixcan) and humans in Chile. PLoS One 2013; 8: e76150. Google Scholar CrossRef Search ADS PubMed 61 Huijbers PM, Blaak H, de Jong MC et al. Role of the environment in the transmission of antimicrobial resistance to humans: a review. Environ Sci Technol 2015; 49: 11993– 2004. Google Scholar CrossRef Search ADS PubMed © The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: email@example.com.
Journal of Antimicrobial Chemotherapy – Oxford University Press
Published: Feb 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera